Filing Flows › Cerenome (CNSY) › Q1 2026 › vs Q1 2025
Cerenome (CNSY) Q1 2026 vs Q1 2025 (year over year)
Cerenome's revenue fell $31K (-3%) from $1.1M in Q1 2025 to $1.0M in Q1 2026.
Cerenome, Q1 2026: revenue $1.0M (-3% year over year), operating margin -692.5%, net loss $6.9M, operating cash flow −$6.2M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.0M | $1.1M | −$31K | -3% |
| Other income, net | $173K | −$13.9M | $14.0M | — |
| Net loss | $6.9M | $17.4M | −$10.5M | -60% |
| Costs & expenses | $8.1M | $18.5M | −$10.3M | -56% |
| Operating costs | $8.1M | $4.6M | $3.6M | +77% |
| Research & development | $2.9M | $1.8M | $1.1M | +63% |
| General & admin | $5.3M | $2.8M | $2.4M | +86% |
| Operating cash sources | $7.4M | $6.5M | $890K | +14% |
| Depreciation & amortization | $96K | $146K | −$50K | -34% |
| Share-based compensation | $1.0M | $148K | $874K | +591% |
| Cash used in operations | $6.2M | $6.2M | $66K | +1% |
| Net loss absorbed | $6.9M | $17.4M | −$10.5M | -60% |
| Working capital & other | $410K | −$10.9M | $11.3M | — |
Questions
How much did Cerenome's revenue grow year over year in Q1 2026?
Cerenome's revenue fell $31K (-3%) from $1.1M in Q1 2025 to $1.0M in Q1 2026.